Eucrates Biomedical Acquisition Corp. Unit

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch EUCRU and buy or sell other stocks, ETFs, and their options commission-free!

About EUCRU

Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company was founded by Stelios Papadopoulos, Parag Saxena, Evangelos Vergetis and Daphne Karydas on August 21, 2020 and is headquartered in New York, NY. 

CEO
Parag Phoolchand Saxena, MBA
CEOParag Phoolchand Saxena, MBA
Employees
—
Employees—
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2020
Founded2020
Employees
—
Employees—

EUCRU Key Statistics

Market cap
42.14M
Market cap42.14M
Price-Earnings ratio
53.35
Price-Earnings ratio53.35
Dividend yield
—
Dividend yield—
Average volume
2.74K
Average volume2.74K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$10.67
52 Week high$10.67
52 Week low
$9.76
52 Week low$9.76
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.